Multiple sclerosis, a treatable disease
This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key feature...
Gespeichert in:
Veröffentlicht in: | Clinical medicine (London, England) England), 2016-12, Vol.16 (6), p.s53-s59 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | s59 |
---|---|
container_issue | 6 |
container_start_page | s53 |
container_title | Clinical medicine (London, England) |
container_volume | 16 |
creator | Doshi, Anisha Chataway, Jeremy |
description | This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key features that can be useful in the clinic. We comment on the diagnostic criteria and review the main subtypes of MS, including clinically isolated syndrome, relapsing remitting MS, secondary progressive MS and primary progressive MS. Although the underlying aetiology of MS is still not known, we summarise those with most evidence of association. Finally, we aim to present treatment strategies for managing the acute relapse, disease-modifying therapies and MS symptoms. This review highlights that progressive MS is an area where there is currently a paucity of available disease-modifying treatments and this will be a major focus for future development. |
doi_str_mv | 10.7861/clinmedicine.16-6-s53 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2672786883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1470211824023303</els_id><sourcerecordid>2672786883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2993-160588f56a328f8361a885cf156855c581a2b47803eb396da5572643f9615f743</originalsourceid><addsrcrecordid>eNqFUE1LAzEQDaJgrf4EoeDBi6n52MzOnkSKX1DxoueQZieQst2tyVbw3xutB2-eZhjee_PeY-xcinmNIK99F_sNtdHHnuYSOPBs9AGbyKrWvMJGH_7sgisp8Zid5LwWQpqqgQm7fN51Y9x2NMu-ozTkmK9mbjYmcqNblXMbM7lMp-wouC7T2e-csrf7u9fFI1--PDwtbpfcq6bRXIIwiMGA0woDapAO0fggDaAx3qB0alXVKDStdAOtM6ZWUOnQgDShrvSUXex1t2l431Ee7XrYpb68tApqVfIi6oIye5QvjnOiYLcpblz6tFLY707s306sBAu2dFJ4N3selQgfkZLNPlLvCzCRH207xH8UvgCP5Gzc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2672786883</pqid></control><display><type>article</type><title>Multiple sclerosis, a treatable disease</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Doshi, Anisha ; Chataway, Jeremy</creator><creatorcontrib>Doshi, Anisha ; Chataway, Jeremy</creatorcontrib><description>This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key features that can be useful in the clinic. We comment on the diagnostic criteria and review the main subtypes of MS, including clinically isolated syndrome, relapsing remitting MS, secondary progressive MS and primary progressive MS. Although the underlying aetiology of MS is still not known, we summarise those with most evidence of association. Finally, we aim to present treatment strategies for managing the acute relapse, disease-modifying therapies and MS symptoms. This review highlights that progressive MS is an area where there is currently a paucity of available disease-modifying treatments and this will be a major focus for future development.</description><identifier>ISSN: 1470-2118</identifier><identifier>EISSN: 1473-4893</identifier><identifier>DOI: 10.7861/clinmedicine.16-6-s53</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Atrophy ; Diagnostic criteria ; epidemiology ; Inflammation ; Magnetic resonance imaging ; Multiple sclerosis ; Nervous system ; progressive multiple sclerosis ; Spinal cord ; treatments ; Young adults</subject><ispartof>Clinical medicine (London, England), 2016-12, Vol.16 (6), p.s53-s59</ispartof><rights>2016 © 2016 THE AUTHORS. Published by Elsevier Limited on behalf of the Royal College of Physicians.</rights><rights>Copyright Royal College of Physicians Dec 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2993-160588f56a328f8361a885cf156855c581a2b47803eb396da5572643f9615f743</citedby><cites>FETCH-LOGICAL-c2993-160588f56a328f8361a885cf156855c581a2b47803eb396da5572643f9615f743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Doshi, Anisha</creatorcontrib><creatorcontrib>Chataway, Jeremy</creatorcontrib><title>Multiple sclerosis, a treatable disease</title><title>Clinical medicine (London, England)</title><description>This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key features that can be useful in the clinic. We comment on the diagnostic criteria and review the main subtypes of MS, including clinically isolated syndrome, relapsing remitting MS, secondary progressive MS and primary progressive MS. Although the underlying aetiology of MS is still not known, we summarise those with most evidence of association. Finally, we aim to present treatment strategies for managing the acute relapse, disease-modifying therapies and MS symptoms. This review highlights that progressive MS is an area where there is currently a paucity of available disease-modifying treatments and this will be a major focus for future development.</description><subject>Atrophy</subject><subject>Diagnostic criteria</subject><subject>epidemiology</subject><subject>Inflammation</subject><subject>Magnetic resonance imaging</subject><subject>Multiple sclerosis</subject><subject>Nervous system</subject><subject>progressive multiple sclerosis</subject><subject>Spinal cord</subject><subject>treatments</subject><subject>Young adults</subject><issn>1470-2118</issn><issn>1473-4893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFUE1LAzEQDaJgrf4EoeDBi6n52MzOnkSKX1DxoueQZieQst2tyVbw3xutB2-eZhjee_PeY-xcinmNIK99F_sNtdHHnuYSOPBs9AGbyKrWvMJGH_7sgisp8Zid5LwWQpqqgQm7fN51Y9x2NMu-ozTkmK9mbjYmcqNblXMbM7lMp-wouC7T2e-csrf7u9fFI1--PDwtbpfcq6bRXIIwiMGA0woDapAO0fggDaAx3qB0alXVKDStdAOtM6ZWUOnQgDShrvSUXex1t2l431Ee7XrYpb68tApqVfIi6oIye5QvjnOiYLcpblz6tFLY707s306sBAu2dFJ4N3selQgfkZLNPlLvCzCRH207xH8UvgCP5Gzc</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Doshi, Anisha</creator><creator>Chataway, Jeremy</creator><general>Elsevier Ltd</general><general>Royal College of Physicians</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201612</creationdate><title>Multiple sclerosis, a treatable disease</title><author>Doshi, Anisha ; Chataway, Jeremy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2993-160588f56a328f8361a885cf156855c581a2b47803eb396da5572643f9615f743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Atrophy</topic><topic>Diagnostic criteria</topic><topic>epidemiology</topic><topic>Inflammation</topic><topic>Magnetic resonance imaging</topic><topic>Multiple sclerosis</topic><topic>Nervous system</topic><topic>progressive multiple sclerosis</topic><topic>Spinal cord</topic><topic>treatments</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Doshi, Anisha</creatorcontrib><creatorcontrib>Chataway, Jeremy</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>UK & Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical medicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Doshi, Anisha</au><au>Chataway, Jeremy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple sclerosis, a treatable disease</atitle><jtitle>Clinical medicine (London, England)</jtitle><date>2016-12</date><risdate>2016</risdate><volume>16</volume><issue>6</issue><spage>s53</spage><epage>s59</epage><pages>s53-s59</pages><issn>1470-2118</issn><eissn>1473-4893</eissn><abstract>This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key features that can be useful in the clinic. We comment on the diagnostic criteria and review the main subtypes of MS, including clinically isolated syndrome, relapsing remitting MS, secondary progressive MS and primary progressive MS. Although the underlying aetiology of MS is still not known, we summarise those with most evidence of association. Finally, we aim to present treatment strategies for managing the acute relapse, disease-modifying therapies and MS symptoms. This review highlights that progressive MS is an area where there is currently a paucity of available disease-modifying treatments and this will be a major focus for future development.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.7861/clinmedicine.16-6-s53</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1470-2118 |
ispartof | Clinical medicine (London, England), 2016-12, Vol.16 (6), p.s53-s59 |
issn | 1470-2118 1473-4893 |
language | eng |
recordid | cdi_proquest_journals_2672786883 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete; PubMed Central; Alma/SFX Local Collection |
subjects | Atrophy Diagnostic criteria epidemiology Inflammation Magnetic resonance imaging Multiple sclerosis Nervous system progressive multiple sclerosis Spinal cord treatments Young adults |
title | Multiple sclerosis, a treatable disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T06%3A20%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20sclerosis,%20a%20treatable%20disease&rft.jtitle=Clinical%20medicine%20(London,%20England)&rft.au=Doshi,%20Anisha&rft.date=2016-12&rft.volume=16&rft.issue=6&rft.spage=s53&rft.epage=s59&rft.pages=s53-s59&rft.issn=1470-2118&rft.eissn=1473-4893&rft_id=info:doi/10.7861/clinmedicine.16-6-s53&rft_dat=%3Cproquest_cross%3E2672786883%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2672786883&rft_id=info:pmid/&rft_els_id=S1470211824023303&rfr_iscdi=true |